Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices.
BACKGROUND
Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS.


OBJECTIVE
The authors assessed and determined current treatment trends in AIDS psychiatry.


METHODS
Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey.


RESULTS
Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam).


CONCLUSIONS
Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.
Freedom Trail Clinic, 25 Staniford, St., Boston, MA 02114, USA. ofreudenreich@partners.org
Oliver
O
Freudenreich
Harold W
HW
Goforth
Kelly L
KL
Cozza
Matthew J
MJ
Mimiaga
Steven A
SA
Safren
Grace
G
Bachmann
Mary Ann
MA
Cohen
D000163:Acquired Immunodeficiency Syndrome / Q000523:psychology; D001007:Anxiety / Q000188:drug therapy; D016001:Confidence Intervals; D003863:Depression / Q000188:drug therapy; D015658:HIV Infections / Q000523:psychology*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011618:Psychotic Disorders / Q000188:drug therapy; D011795:Surveys and Questionnaires